Customized and Designed Micro- and Nanocarriers for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 26
Special Issue Editor
Interests: drug delivery system; biopolymer; stimuli-responsive; particle; biological application; fiber
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The advancement and potential of drug delivery systems offer new opportunities to address treatment challenges for various diseases, particularly due to the non-specific diffusion of free drugs. It is essential to conduct comprehensive research across scientific and technological domains to facilitate the creation of new effective strategies. Consequently, the creation of stable vehicles becomes crucial for significantly improving the pharmacokinetics and biodistribution of therapeutic agents.
I am pleased to announce that we are seeking the submission of articles for this Special Issue focusing on the recent advancements (over the past 10 years) in using micro- and nanocarriers for drug delivery systems in biological applications. We welcome submissions covering all aspects of carrier utilization, such as particles and fibers, aimed at achieving significantly enhanced therapeutic effectiveness.
Let us discuss how carrier properties are correlated with their biological purpose in order to improve drug delivery from the infusion site to the intracellular target site, aiming to overcome biological obstacles and ensure that the drug reaches its intended destination.
Dr. Sabrina Belbekhouche
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carrier
- drug delivery system
- biotechnology
- biological purpose
- particles
- fibers
- nanocarrier
- microcarrier
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
